Bayer's $2.2B Ohio Site Boosts U.S. Pharma | Pharma and Biotech Daily

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of groundbreaking advancements and strategic shifts that are defining the industry's path forward.

Bayer has made headlines with its strategic $2.2 billion investment in a new Ohio manufacturing site. This move highlights the critical importance of strengthening domestic manufacturing capabilities, especially within the context...